Terms: = Skin cancer AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300 AND Prognosis
8 results:
1. Integrative Genomic Profiling Uncovers Therapeutic Targets of Acral Melanoma in Asian Populations.
Shi Q; Liu L; Chen J; Zhang W; Guo W; Wang X; Wang H; Guo S; Yue Q; Ma J; Liu Y; Zhu G; Zhao T; Zhao J; Liu Y; Gao T; Li C
Clin Cancer Res; 2022 Jun; 28(12):2690-2703. PubMed ID: 35294533
[TBL] [Abstract] [Full Text] [Related]
2. Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features.
Zhou XA; Yang J; Ringbloom KG; Martinez-Escala ME; Stevenson KE; Wenzel AT; Fantini D; Martin HK; Moy AP; Morgan EA; Harkins S; Paxton CN; Hong B; Andersen EF; Guitart J; Weinstock DM; Cerroni L; Choi J; Louissaint A
Blood Adv; 2021 Feb; 5(3):649-661. PubMed ID: 33560380
[TBL] [Abstract] [Full Text] [Related]
3. The Tumor-Promoting Role of TRIP4 in Melanoma Progression and its Involvement in Response to BRAF-Targeted Therapy.
Hao J; Xu H; Luo M; Yu W; Chen M; Liao Y; Zhang C; Zhao X; Jiang W; Hou S; Feng X; Zou K; Chen Y; Huang W; Guo W; Kang L; Deng W
J Invest Dermatol; 2018 Jan; 138(1):159-170. PubMed ID: 28899685
[TBL] [Abstract] [Full Text] [Related]
4. Overexpression of p300 correlates with poor prognosis in patients with cutaneous squamous cell carcinoma.
Chen MK; Cai MY; Luo RZ; Tian X; Liao QM; Zhang XY; Han JD
Br J Dermatol; 2015 Jan; 172(1):111-9. PubMed ID: 24975674
[TBL] [Abstract] [Full Text] [Related]
5. A combination of p300 and Braf expression in the diagnosis and prognosis of melanoma.
Bhandaru M; Ardekani GS; Zhang G; Martinka M; McElwee KJ; Li G; Rotte A
BMC Cancer; 2014 Jun; 14():398. PubMed ID: 24893747
[TBL] [Abstract] [Full Text] [Related]
6. The aggregation of mutant p53 produces prion-like properties in cancer.
Rangel LP; Costa DC; Vieira TC; Silva JL
Prion; 2014; 8(1):75-84. PubMed ID: 24509441
[TBL] [Abstract] [Full Text] [Related]
7. Decreased expression of nuclear p300 is associated with disease progression and worse prognosis of melanoma patients.
Rotte A; Bhandaru M; Cheng Y; Sjoestroem C; Martinka M; Li G
PLoS One; 2013; 8(9):e75405. PubMed ID: 24098694
[TBL] [Abstract] [Full Text] [Related]
8. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease.
Binks M; Passweg JR; Furst D; McSweeney P; Sullivan K; Besenthal C; Finke J; Peter HH; van Laar J; Breedveld FC; Fibbe WE; Farge D; Gluckman E; Locatelli F; Martini A; van den Hoogen F; van de Putte L; Schattenberg AV; Arnold R; Bacon PA; Emery P; Espigado I; Hertenstein B; Hiepe F; Kashyap A; Kötter I; Marmont A; Martinez A; Pascual MJ; Gratwohl A; Prentice HG; Black C; Tyndall A
Ann Rheum Dis; 2001 Jun; 60(6):577-84. PubMed ID: 11350846
[TBL] [Abstract] [Full Text] [Related]
